Natixis Cortexyme, Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 12, 2021	SELL	$27.78 - $56.93 $169,846 - $348,070	-6,114 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$39.85 - $57.3 $241,769 - $347,639	-6,067 Reduced 49.81%	6,114 $306,000
Q2 2020 Aug 13, 2020	SELL	$34.93 - $57.75 $154,181 - $254,908	-4,414 Reduced 26.6%	12,181 $564,000
Q1 2020 May 14, 2020	BUY	$29.01 - $72.51 $132,981 - $332,385	4,584 Added 38.17%	16,595 $757,000
Q4 2019 Feb 14, 2020	SELL	$20.77 - $68.91 $13,168 - $43,688	-634 Reduced 5.01%	12,011 $674,000
Q3 2019 Nov 13, 2019	BUY	$19.85 - $45.28 $251,003 - $572,565	12,645 New	12,645 $315,000

Others Institutions Holding CRTX

# of Institutions

39

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

0

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.55 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

826K
Shares

$1.07 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

523K
Shares

$674,123
0.0% of portfolio
Almitas Capital LLC Santa Monica, CA

383K
Shares

$493,917
0.23% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.